Henry Meds charges no consultation fees, and its refund policy is not stated
Reading Published Dose Ranges Correctly Retatrutides Phase 3 TRIUMPH-1 trial, with topline results reported by Eli Lilly in May 2026, evaluated three target doses 4mg, 9mg, and 12mg weekly with all arms starting at 2mg and escalating in steps every four weeks (2mg 4mg 6mg 9mg 12mg, depending on target arm) rather than starting at the target dose directly
Endocrinology, Diabetes & Metabolism Case Reports
Now, all eyes are on the FDA, which has stated that compounding is only permissible if its not done regularly or in inordinate amounts. Given how widespread and normalized compounded GLP-1s have becomewith many people micro-dosing, stretching out doses or following DIY regimensit may only be a matter of time before regulators start cracking down
The choice between these medications is highly individual and depends on how your body responds to each compound's unique mechanism
Study findings The simulation indicated a measurable reduction in BoNT-A treatment duration across all GLP-1 groups when compared with controls
